Clinical Trial Update: Efficacy of LL-37 Cream on Bacteria Colonization, Inflammation Response and Healing Rate of Diabetic Foot Ulcers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LL-37 cream for reducing bacterial colonization, inflammation, and improving healing in diabetic foot ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• LL-37 cream (LL-37)

Snippet

Sponsor: Fakultas Kedokteran Universitas Indonesia | Conditions: Diabetic Foot Ulcer | Phase 2 | Status: UNKNOWN